Current studies have demonstrated that TUSC2 might play a tumor-suppressing role through inducing apoptosis, arresting the G1 cell cycle, and inhibiting proliferation-related kinases, e.g., EGFR, mTOR, and AKT [24]. The gene discussed is EGFR; the disease is neoplasm.